Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taehoon Lee

Showing results (141-150 of 167) with videos related to

Pageof 17
Sort By:
ERJ Open Research|March 11, 2026
Characteristics and asthma control status in the Korean Severe Asthma Registry-2: a real-world analysisJoo-Hee Kim, Hyun Lee, Sun-Kyung Lee, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 13, 2020
A Randomized, Noninferiority Trial Comparing ICS + LABA with ICS + LABA + LAMA in Asthma-COPD Overlap (ACO) Treatment: The ACO Treatment with Optimal Medications (ATOMIC) StudySo-Young Park, Solmi Kim, Jung-Hyun Kim, et al.
Lancet (London, England)|December 15, 2022
9 months of delamanid, linezolid, levofloxacin, and pyrazinamide versus conventional therapy for treatment of fluoroquinolone-sensitive multidrug-resistant tuberculosis (MDR-END): a multicentre, randomised, open-label phase 2/3 non-inferiority trial in South KoreaJeongha Mok, Myungsun Lee, Deog Kyeom Kim, et al.
The World Allergy Organization Journal|December 14, 2023
A comparison of treatment response to biologics in asthma-COPD overlap and pure asthma: Findings from the PRISM studyJi-Su Shim, Hyunkyoung Kim, Jae-Woo Kwon, et al.
Allergy, Asthma & Immunology Research|June 24, 2024
Characteristics of Severe Asthma in the Elderly: Observations From the Korean Severe Asthma Registry (KoSAR)Hwa Young Lee, Da Woon Sim, Youngsoo Lee, et al.
Respiration; International Review of Thoracic Diseases|December 16, 2021
Clusters of Severe Eosinophilic Asthma in a Korean Asthma CohortJi-Hyang Lee, Jin An, Ha-Kyeong Won, et al.
Trials|January 18, 2019
Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III, multicenter, randomized, open-label clinical trialMyungsun Lee, Jeongha Mok, Deog Kyeom Kim, et al.
Allergy, Asthma & Immunology Research|July 30, 2025
Prevalence and Clinical Characteristics of Severe Asthma With Fungal Sensitization in KoreaHyo-In Rhyou, Tae-Bum Kim, Sun-Young Yoon, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 16, 2025
Reply to "Optimizing FeNO and blood eosinophil stratification in eosinophilic asthma study: Adjusting for smoking history and blood sampling time"Duong Duc Pham, Ji-Hyang Lee, Hyouk-Soo Kwon, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 2, 2023
WITHDRAWN: Prospective direct comparison of biological treatments on severe eosinophilic asthma: Findings from the PRISM studyDuong Duc Pham, Ji-Hyang Lee, Hyouk-Soo Kwon, et al.
Pageof 17

Showing results (141-150 of 167) with videos related to

Sort By:
Pageof 17
ERJ Open Research|March 11, 2026
Characteristics and asthma control status in the Korean Severe Asthma Registry-2: a real-world analysisJoo-Hee Kim, Hyun Lee, Sun-Kyung Lee, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 13, 2020
A Randomized, Noninferiority Trial Comparing ICS + LABA with ICS + LABA + LAMA in Asthma-COPD Overlap (ACO) Treatment: The ACO Treatment with Optimal Medications (ATOMIC) StudySo-Young Park, Solmi Kim, Jung-Hyun Kim, et al.
Lancet (London, England)|December 15, 2022
9 months of delamanid, linezolid, levofloxacin, and pyrazinamide versus conventional therapy for treatment of fluoroquinolone-sensitive multidrug-resistant tuberculosis (MDR-END): a multicentre, randomised, open-label phase 2/3 non-inferiority trial in South KoreaJeongha Mok, Myungsun Lee, Deog Kyeom Kim, et al.
The World Allergy Organization Journal|December 14, 2023
A comparison of treatment response to biologics in asthma-COPD overlap and pure asthma: Findings from the PRISM studyJi-Su Shim, Hyunkyoung Kim, Jae-Woo Kwon, et al.
Allergy, Asthma & Immunology Research|June 24, 2024
Characteristics of Severe Asthma in the Elderly: Observations From the Korean Severe Asthma Registry (KoSAR)Hwa Young Lee, Da Woon Sim, Youngsoo Lee, et al.
Respiration; International Review of Thoracic Diseases|December 16, 2021
Clusters of Severe Eosinophilic Asthma in a Korean Asthma CohortJi-Hyang Lee, Jin An, Ha-Kyeong Won, et al.
Trials|January 18, 2019
Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III, multicenter, randomized, open-label clinical trialMyungsun Lee, Jeongha Mok, Deog Kyeom Kim, et al.
Allergy, Asthma & Immunology Research|July 30, 2025
Prevalence and Clinical Characteristics of Severe Asthma With Fungal Sensitization in KoreaHyo-In Rhyou, Tae-Bum Kim, Sun-Young Yoon, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 16, 2025
Reply to "Optimizing FeNO and blood eosinophil stratification in eosinophilic asthma study: Adjusting for smoking history and blood sampling time"Duong Duc Pham, Ji-Hyang Lee, Hyouk-Soo Kwon, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 2, 2023
WITHDRAWN: Prospective direct comparison of biological treatments on severe eosinophilic asthma: Findings from the PRISM studyDuong Duc Pham, Ji-Hyang Lee, Hyouk-Soo Kwon, et al.
Pageof 17